Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone therapy: an overview

P H Smith1

  • 1Department of Urology, St James's Hospital, Leeds.

Cancer Surveys
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Hormonal treatments for prostate cancer show limited progress. While total androgen ablation offers a survival benefit, it is not a cure, highlighting the need for novel therapeutic strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct cell classes in the superior paraolivary nucleus (SPN) region in the gerbil auditory brainstem revealed by in vivo physiological and anatomical characterization.

Hearing research·2025
Same author

Variations in color and reflectance on the surface of asteroid (101955) Bennu.

Science (New York, N.Y.)·2020
Same author

Ground and In-Flight Calibration of the OSIRIS-REx Camera Suite.

Space science reviews·2020
Same author

The operational environment and rotational acceleration of asteroid (101955) Bennu from OSIRIS-REx observations.

Nature communications·2019
Same author

The unexpected surface of asteroid (101955) Bennu.

Nature·2019
Same author

Interactions between autonomic nerves and endocrine cells of the gastroenteropancreatic system.

Diabetologia·2016
Same journal

Future directions: bladder cancer.

Cancer surveys·2004
Same journal

Radiotherapy and chemotherapy for invasive bladder cancer.

Cancer surveys·2004
Same journal

The role of surgery in the multimodality treatment of bladder cancer.

Cancer surveys·2004
Same journal

Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.

Cancer surveys·2004
Same journal

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Cancer surveys·2004
Same journal

Molecular biological changes in bladder cancer.

Cancer surveys·2004
See all related articles

Area of Science:

  • Oncology
  • Endocrinology

Background:

  • Prostate cancer treatment has seen minimal advancement in hormonal therapies over the last two decades.
  • Current hormonal approaches, including total androgen ablation and stilboestrol use, offer modest survival advantages but do not provide a cure.

Purpose of the Study:

  • To review the current state of hormonal treatment for prostate cancer.
  • To identify limitations of existing therapies and underscore the need for new treatment development.

Main Methods:

  • Review of existing literature on prostate cancer hormonal therapies.
  • Analysis of survival data associated with different treatment modalities.

Main Results:

  • Total androgen ablation demonstrates a potential 20% survival advantage over monotherapy.

Related Experiment Videos

  • Stilboestrol may offer benefits if cardiovascular side effects are mitigated.
  • Current cytotoxic chemotherapy provides limited survival benefits.

    • Conclusions:

    • Existing hormonal treatments for prostate cancer are insufficient for achieving a cure.
    • There is an urgent requirement for the development of innovative and more effective prostate cancer treatments.